Hologic’s HOLX Genius Digital Diagnostics System has achieved expanded CE marking in the European Union. The development signals a promising step in the company’s innovation pipeline focused on ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that its new Genius™ Digital Diagnostics System is now CE marked in Europe. Genius Digital Diagnostics is the first ...

Through a Combination of Advanced Imaging and Novel Artificial Intelligence, Latest Diagnostic System for Cervical Cancer Screening Can Help More Accurately Detect Disease, Improve Workflow and ...

The Genius Digital Diagnostics System now offers European labs the ability to streamline digital pathology workflows using one complete solution for a variety of specimen types MARLBOROUGH, ...

For the second time just this week, an artificial intelligence-powered tool aimed at improving cervical cancer screening is taking center stage. This time around, Hologic is the star of the show. Its ...

Medical technology firm Hologic has been granted clearance from the FDA to market its Genius Digital Diagnostics System, powered by the company's Genius Cervical AI algorithm. The digital cytology ...

Hologic Inc.’s focus on women’s health is looking like a brilliant move as the company lands U.S. FDA clearance for its Genius digital diagnostics system with the Genius cervical artificial ...

Hologic (NASDAQ:HOLX) has received approval from the U.S. Food and Drug Administration (FDA) approval for its new digital cytology system, making it the first FDA-cleared digital cytology platform.